Ensure you obtain this medication legally by consulting with your healthcare provider and choosing a pharmacy
To learn more about the causes of ataxia, visit Johns Hopkins Medicine
This is particularly concerning as obesity is more prevalent among socioeconomically disadvantaged groups, particularly among women, according to area level deprivation and household income [27, 28]
Potential health risks:** While these drugs can aid weight loss, they are potent medications with side effects such as nausea, gastrointestinal issues, and, in some cases, more serious health concernsespecially if used without medical supervision
The most common semaglutide injection sites are the abdomen, thigh, and upper arm
References Growing rates of overweight and obesity in Australia - Australian Institute of Health and Welfare Imported unregistered GLP-1 weight-loss products | Therapeutic Goods Administration (TGA) Pharmaceutical Benefits Advisory Committee (PBAC) advice on equitable access to GLP-1 obesity treatments | Pharmaceutical Benefits Scheme (PBS) GLP-1 Weight Loss Medications Explained Simply Am I Eligible for Weight Loss Medication in Australia
